SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-004502
Filing Date
2020-01-16
Accepted
2020-01-16 09:34:47
Documents
7
Period of Report
2020-01-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm203484-1_8k.htm 8-K 38657
2 EXHIBIT 2.1 tm203484d1_ex2-1.htm EX-2.1 543562
3 EXHIBIT 99.1 tm203484d1_ex99-1.htm EX-99.1 65109
4 EXHIBIT 99.2 tm203484d1_ex99-2.htm EX-99.2 28044
5 GRAPHIC tm203484d1_ex99-2img001.jpg GRAPHIC 6411
6 GRAPHIC tm203484d1_ex99-2img002.jpg GRAPHIC 3805
7 GRAPHIC tm203484d1_ex99-2img003.jpg GRAPHIC 3559
  Complete submission text file 0001104659-20-004502.txt   696023
Mailing Address 40 ERIE STREET SUITE 110 CAMBRIDGE MA 02139
Business Address 40 ERIE STREET SUITE 110 CAMBRIDGE MA 02139 617-337-4701
Neon Therapeutics, Inc. (Filer) CIK: 0001694187 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38551 | Film No.: 20529624
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences